Simon Amy 4
4 · Beam Therapeutics Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Simon Amy
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-07-03$20.12/sh−876$17,625→ 64,864 total - Sale
Common Stock
2025-07-01$16.94/sh−374$6,336→ 65,740 total
Footnotes (3)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan on June 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
- [F2]Includes 372 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2024.
- [F3]These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.